Краткая история развития эндоваскулярных методов лечения острого ишемического инсульта


В.С. Смит, А.Дж. Фурлан

Department of Neurology, University of California, San Francisco; Department of Neurology, Neurological Institute, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH.

Литература


  1. Zeumer H., Hacke W., Ringelstein E.B. Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease. AJNR Am J Neuroradiol. 1983;4:401–404.
  2. del Zoppo G.J., Higashida R.T., Furlan A.J., Pessin M.S., Rowley H.A., Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke. 1998;29:4–11.
  3. Furlan A., Higashida R., Wechsler L., Gent M., Rowley H., Kase C., ­et al. Intra-arterial prourokinase for acute ischemic stroke. ­The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282:2003–2011.
  4. Jovin T.G., Chamorro A., Cobo E., de Miquel M.A., Molina C.A., Rovira A., et al; REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372:2296–2306. doi: 10.1056/NEJMoa1503780.
  5. Felten R.P., Ogden N.R., Peña C., Provost M.C., Schlosser M.J., Witten C.M. The Food and Drug Administration medical device review process: clearance of a clot retriever for use in ischemic stroke. Stroke. 2005;36:404–406. doi: 10.1161/01.STR.0000153063.54972.91.
  6. Smith W.S., Sung G., Starkman S., Saver J.L., Kidwell C.S., Gobin Y.P., et al; MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results ­of the MERCI trial. Stroke. 2005;36:1432–1438. doi: 10.1161/01.STR.0000171066.25248.1d.
  7. Becker K.J., Brott T.G. Approval of the MERCI clot retriever:­ a critical view. Stroke. 2005;36:400–403. doi: 10.1161/01.STR.0000153056.25397.ff.
  8. Furlan A.J., Fisher M. Devices, drugs, and the Food and Drug Administration: increasing implications for ischemic stroke. Stroke. 2005;36:398–399. doi: 10.1161/01.STR.0000153057.07181.94.
  9. Josephson S.A., Saver J.L., Smith W.S.; Merci and Multi Merci Investigators. Comparison of mechanical embolectomy and intraarterial thrombolysis in acute ischemic stroke within the MCA: MERCI and Multi MERCI compared to PROACT II. Neurocrit Care. 2009;10:43–49. doi: 10.1007/s12028-008-9167-7.
  10. Smith W.S., Sung G., Saver J., Budzik R., Duckwiler G., Liebeskind D.S., et al; Multi MERCI Investigators. Mechanical thrombectomy ­for acute ischemic stroke: final results of the Multi MERCI trial. Stroke. 2008;39:1205–1212. doi: 10.1161/STROKEAHA.107.497115.
  11. Broderick J.P., Palesch Y.Y., Demchuk A.M., Yeatts S.D., Khatri P., Hill M.D., et al; Interventional Management of Stroke (IMS) III Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013;368:893–903. ­doi: 10.1056/NEJMoa1214300.
  12. Demchuk A.M., Goyal M., Yeatts S.D., Carrozzella J., Foster L.D., Qazi E., et al; IMS III Investigators. Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial. Radiology. 2014;273:202–210. ­doi: 10.1148/radiol.14132649.
  13. Kelly M.E., Furlan A.J., Fiorella D. Recanalization of an acute middle cerebral artery occlusion using a self-expanding, reconstrainable, intracranial microstent as a temporary endovascular bypass. Stroke. 2008;39:1770–1773. doi: 10.1161/STROKEAHA.107.506212.
  14. Castaño C., Serena J., Dávalos A. Use of the new solitaire ™ AB device for mechanical thrombectomy when Merci clot retriever has failed to remove the clot. A case report. Interv Neuroradiol. 2009;15:209–214.


Бионика Медиа